Literature DB >> 9208889

Mucocutaneous paraneoplastic syndromes.

P R Cohen1, R Kurzrock.   

Abstract

Mucocutaneous paraneoplastic syndromes represent a group of dermatoses of variable morphology, pathology, and etiology that can occur as idiopathic conditions or in association with a visceral malignancy. These conditions can be categorized with respect to their predominant pathologic change: dermal "depositions," neutrophilic dermatoses, papulosquamous disorders, proliferative reactions, reactive erythemas, vacuolar degeneration of the basal layer, vasculitis, and vesiculobullous disorders. Some of these dermatoses occur more frequently in patients with hematologic malignancies whereas others are more prevalent in patients with solid tumors. The major clinical characteristics and commonly associated malignancies in patients with mucocutaneous paraneoplastic syndromes are reviewed. Suggested workups to evaluate for cancer in patients with these dermatoses are summarized. The appearance of a mucocutaneous paraneoplastic syndrome can either precede, occur concurrently with, or follow the detection of an associated neoplastic process. Therefore, the dermatosis can be the presenting feature of a previously unsuspected neoplasm or the earliest sign of recurrent cancer in an oncology patient. When the possibility of a mucocutaneous paraneoplastic syndrome is entertained, the diagnosis of the dermatosis should be confirmed either based on the clinical morphology of the lesions, the pathologic changes observed after lesional biopsy, or both. Once the diagnosis of a malignancy-associated dermatosis has been established, either an appropriate evaluation for an asymptomatic neoplasm in a cancer-free individual or an investigation for recurrence of malignancy in an oncology patient can be initiated.

Entities:  

Mesh:

Year:  1997        PMID: 9208889

Source DB:  PubMed          Journal:  Semin Oncol        ISSN: 0093-7754            Impact factor:   4.929


  6 in total

1.  Pityriasis lichenoids chronica as a paraneoplastic dermatosis for primary splenic diffuse large B cell lymphoma.

Authors:  Ying-Yi Lu; Jia-Bin Liao; Chieh-Shan Wu; Chien-Hui Hong
Journal:  Indian J Hematol Blood Transfus       Date:  2014-02-05       Impact factor: 0.900

Review 2.  Adverse reactions to targeted and non-targeted chemotherapeutic drugs with emphasis on hypersensitivity responses and the invasive metastatic switch.

Authors:  Brian A Baldo; Nghia H Pham
Journal:  Cancer Metastasis Rev       Date:  2013-12       Impact factor: 9.264

3.  Paraneoplastic SIADH and Dermatomyositis in Cervical Cancer: A Case Report and Literature Review.

Authors:  Guy Jones; Dolly Razdan; Bernadette Cracchiolo; Karen Houck; Leroy Sharer
Journal:  Case Rep Oncol       Date:  2009-11-14

4.  Cutaneous vasculitis in breast cancer treated with chemotherapy.

Authors:  Maida Wong; Jennifer Grossman; Bevra H Hahn; Antonio La Cava
Journal:  Clin Immunol       Date:  2008-07-21       Impact factor: 3.969

5.  Proton pump inhibitor-induced Sweet's syndrome: report of acute febrile neutrophilic dermatosis in a woman with recurrent breast cancer.

Authors:  Philip R Cohen
Journal:  Dermatol Pract Concept       Date:  2015-04-30

Review 6.  Sweet's syndrome--a comprehensive review of an acute febrile neutrophilic dermatosis.

Authors:  Philip R Cohen
Journal:  Orphanet J Rare Dis       Date:  2007-07-26       Impact factor: 4.123

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.